Radvanyi, F.

mutation tumor urine cancer patient bladder eortc fgfr 3 mutation grade score fgfr 3 mutations eortc risk scores eortc risk score progression analysis microsatellite marker bladder cancer study recurrence carcinoma cytology table alteration detection microsatellite alterations urothelial fgfr 3 status stage follow-up van der kwast variable european fgfr 3 urothelial carcinoma urology number sample analyses world health organization status multivariable nmibc sensitivity european organization fgfr 3 gene result organization rhijn prediction hospital university van rhijn method rotterdam factor multivariable analyses microsatellite analysis research kwast pun-lmp 2001. reproducibility receptor growth 4 p 16.3. addition zwarthoff urine samples expression health university health network –muscle bladder cancer 4s f 5 department series survival treatment diagnosis prognosis